Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 3
1952 11
1953 17
1954 9
1955 12
1956 5
1957 11
1958 11
1959 10
1960 5
1961 5
1962 1
1963 3
1964 3
1965 2
1967 1
1968 2
1969 2
1970 2
1971 1
1972 1
1973 1
1974 2
1975 7
1976 21
1977 14
1978 7
1979 10
1980 6
1981 12
1982 15
1983 14
1984 10
1985 10
1986 14
1987 14
1988 9
1989 8
1990 10
1991 14
1992 12
1993 12
1994 9
1995 12
1996 11
1997 10
1998 18
1999 17
2000 6
2001 11
2002 18
2003 18
2004 14
2005 20
2006 21
2007 25
2008 26
2009 15
2010 15
2011 19
2012 27
2013 20
2014 24
2015 17
2016 23
2017 23
2018 25
2019 17
2020 20
2021 20
2022 22
2023 23
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

822 results

Results by year

Filters applied: . Clear all
Page 1
Hyoscine butylbromide: a review of its use in the treatment of abdominal cramping and pain.
Tytgat GN. Tytgat GN. Drugs. 2007;67(9):1343-57. doi: 10.2165/00003495-200767090-00007. Drugs. 2007. PMID: 17547475 Review.
The bioavailability of hyoscine butylbromide, estimated from renal excretion, was generally <1%. However, because of its high tissue affinity for muscarinic receptors, hyoscine butylbromide remains available at the site of action in the intestine an …
The bioavailability of hyoscine butylbromide, estimated from renal excretion, was generally <1%. However, because of its hi …
Hyoscine butylbromide mode of action on bowel motility: From pharmacology to clinical practice.
Corsetti M, Forestier S, Jiménez M. Corsetti M, et al. Neurogastroenterol Motil. 2023 Apr;35(4):e14451. doi: 10.1111/nmo.14451. Epub 2022 Aug 16. Neurogastroenterol Motil. 2023. PMID: 35972266 Review.
BACKGROUND: Hyoscine butylbromide (HBB) has been available for use as an antispasmodic since 1951 and is indicated for the treatment of abdominal pain associated with cramps. ...
BACKGROUND: Hyoscine butylbromide (HBB) has been available for use as an antispasmodic since 1951 and is indicated for the tre …
Hyoscine N-butylbromide (Buscopan) in the treatment of acute ureteral colic: what is the evidence?
Papadopoulos G, Bourdoumis A, Kachrilas S, Bach C, Buchholz N, Masood J. Papadopoulos G, et al. Urol Int. 2014;92(3):253-7. doi: 10.1159/000358015. Epub 2014 Feb 26. Urol Int. 2014. PMID: 24576895 Free article. Review.
OBJECTIVE: To investigate the evidence for the use of hyoscine N-butylbromide (HBB) in the treatment of acute renal colic. METHODS: A literature search was performed using the keywords 'hyoscine N-butylbromide', 'ureteral colic', 'spasmolytic', 'antich …
OBJECTIVE: To investigate the evidence for the use of hyoscine N-butylbromide (HBB) in the treatment of acute renal colic. MET …
Does hyoscine butylbromide really improve polyp detection during colonoscopy? A meta-analysis of randomized controlled trials.
Cui PJ, Yao J, Han HZ, Zhao YJ, Yang J. Cui PJ, et al. World J Gastroenterol. 2014 Jun 14;20(22):7034-9. doi: 10.3748/wjg.v20.i22.7034. World J Gastroenterol. 2014. PMID: 24944499 Free PMC article. Review.
AIM: To investigate the benefits of hyoscine butylbromide in polyp detection during colonoscopy by a meta-analysis of available randomized controlled trials (RCTs). ...There were no significant differences between the treated and the control group (OR = 1.13, 95%CI: …
AIM: To investigate the benefits of hyoscine butylbromide in polyp detection during colonoscopy by a meta-analysis of availabl …
Cardiovascular effects of hyoscine butylbromide in patients under general anaesthesia.
Quintero C, Molano MF, Amaya S, Maya JJ, Andrade MJ. Quintero C, et al. J Perioper Pract. 2023 Jul-Aug;33(7-8):211-216. doi: 10.1177/17504589211072698. Epub 2022 Mar 14. J Perioper Pract. 2023. PMID: 35285310
BACKGROUND: Cardiovascular effects for drugs such as hyoscine butylbromide are poorly documented in the literature, unlike atropine, which is considered the antimuscarinic of choice in the presence of intraoperative bradycardia. ...RESULTS: The average dose of 0.15m …
BACKGROUND: Cardiovascular effects for drugs such as hyoscine butylbromide are poorly documented in the literature, unlike atr …
Hyoscine butylbromide - a review on its parenteral use in acute abdominal spasm and as an aid in abdominal diagnostic and therapeutic procedures.
Tytgat GN. Tytgat GN. Curr Med Res Opin. 2008 Nov;24(11):3159-73. doi: 10.1185/03007990802472700. Epub 2008 Oct 10. Curr Med Res Opin. 2008. PMID: 18851775 Review.
BACKGROUND: Being a quaternary ammonium compound derived from scopolamine, the alkaloid hyoscine butylbromide (HBB) exerts anticholinergic effects without side effects related to the central nervous system because it does not pass the blood-brain barrier. ...
BACKGROUND: Being a quaternary ammonium compound derived from scopolamine, the alkaloid hyoscine butylbromide (HBB) exerts ant …
Effect of hyoscine N-butylbromide on adenoma detection rate: meta-analysis of randomized clinical trials.
Madhoun MF, Ali T, Tierney WM, Maple JT. Madhoun MF, et al. Dig Endosc. 2015 Mar;27(3):354-60. doi: 10.1111/den.12340. Epub 2014 Oct 16. Dig Endosc. 2015. PMID: 25115416 Review.
BACKGROUND AND AIM: Anti-spasmodic drugs may facilitate mucosal inspection during colonoscopy. The impact of hyoscine N-butylbromide (HBB) on polyp detection rate (PDR) and adenoma detection rate (ADR) is unclear. ...
BACKGROUND AND AIM: Anti-spasmodic drugs may facilitate mucosal inspection during colonoscopy. The impact of hyoscine N-butylbromi …
Hyoscine butylbromide in pain reduction associated with ultrasound-guided manual vacuum aspiration: a randomized placebo-controlled trial.
Chung JPW, Law TSM, Mak JSM, Liu RCY, Sahota DS, Li TC. Chung JPW, et al. Reprod Biomed Online. 2022 Feb;44(2):295-303. doi: 10.1016/j.rbmo.2021.10.011. Epub 2021 Oct 25. Reprod Biomed Online. 2022. PMID: 34949538 Clinical Trial.
Participants were assigned to receive a 1-ml intravenous injection containing 20-mg hyoscine butylbromide (HBB) (n=55) or saline (n =56) as a control immediately before USG-MVA. ...
Participants were assigned to receive a 1-ml intravenous injection containing 20-mg hyoscine butylbromide (HBB) (n=55) or sali …
Hyoscine butylbromide for colorectal polyp detection: prospective, randomized, placebo-controlled trial.
Dos Santos CEO, Moreira H, Pereira-Lima JC, Ribas CAPM, de Quadros Onófrio F, Czecko AEA, Ramos RK, de Carvalho CA. Dos Santos CEO, et al. Clinics (Sao Paulo). 2017 Jul;72(7):395-399. doi: 10.6061/clinics/2017(07)01. Clinics (Sao Paulo). 2017. PMID: 28792997 Free PMC article. Clinical Trial.
In the placebo group 281 lesions were diagnosed (202 adenomas) and in the hyoscine group 282 lesions were detected (189 adenomas) (p=0.23). The PDR and ADR were similar between the placebo and hyoscine groups (64% vs 66% and 50% vs 47%, respectively). ...CONCLUSION: …
In the placebo group 281 lesions were diagnosed (202 adenomas) and in the hyoscine group 282 lesions were detected (189 adenomas) (p= …
822 results